All posts tagged "Johnson & Johnson"
Record $417M award in lawsuit linking baby powder to cancer
Johnson & Johnson insists scientific evidence supports baby powder's safety
- Posted August 21, 2017
Johnson & Johnson settles Oregon suit over Motrin buyback
Supplies of the painkiller manufactured in Puerto Rico failed to dissolve properly
- Posted May 11, 2017
Johnson & Johnson in Early Talks to Buy Drugmaker Actelion
NEW YORK — Johnson & Johnson is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals. Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson &...
- Posted November 25, 2016
Does baby powder cause cancer? Another jury says yes
TRENTON, N.J. — For the third time, Johnson & Johnson has been hit with a multimillion-dollar jury verdict over whether the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene. Late...
- Posted October 28, 2016
Jury awards more than $70M to woman in baby powder lawsuit
ST. LOUIS — A St. Louis jury on Thursday awarded a California woman more than $70 million in her lawsuit alleging that years of using Johnson & Johnson’s baby powder caused her cancer, the latest case raising...
- Posted October 28, 2016
Johnson & Johnson to Buy Abbott’s Vision Unit for $4.33B
NEW YORK – Johnson & Johnson said Friday that it is paying more than $4.3 billion in cash to buy the eye health unit of Abbott Laboratories as it seeks to boost its vision business. The unit,...
- Posted September 16, 2016
Companies Eye Partnership Deals to Counter Low Growth
Survey across 45 countries reveals 40% of firms plan to enter alliances of some kind
- Posted April 25, 2016
Johnson & Johnson, Viacyte Testing Possible Diabetes Cure
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They’ve...
- Posted February 4, 2016
Johnson & Johnson Beats 4Q Profit Forecasts
Johnson & Johnson posted a 28 percent jump in fourth-quarter profit with the sale of its heart devices unit offsetting a weak performance from what was once its top moneymaker, as well as the strong dollar and...
- Posted January 26, 2016
Johnson & Johnson to Cut about 3,000 Jobs in Medical Devices
Johnson & Johnson said Tuesday that it plans to cut about 3,000 jobs over the next two years as the health care conglomerate works to restructure its medical devices business. The New Brunswick, New Jersey, company said...
- Posted January 19, 2016